February 21, 2025
BRYAN DOZIER/Middle East Images/AFP via Getty Images

Mass layoffs leave federal employees with disabilities in the lurch

Employees with disabilities, often on a two-year probation, were especially vulnerable during the Trump administration's mass layoffs.

By O. Rose Broderick and Angus Chen


Federal judge extends restraining order on Trump administration’s cap on NIH indirect costs

The temporary restraining order was set to expire on Monday, but has been extended until the judge can make a final decision on an injunction

By Anil Oza


STAT+ | Bluebird Bio sells itself to Carlyle, SK Capital for less than $30 million

The company's sale marks a quiet end for a once-high-flying biotech that was set to run out of cash virtually any day

By Jason Mast



Herbert Kickl, leader of Austria's far-right Freedom Party, speaks at a rally in the city of Innsbruck protesting coronavirus-related restrictions in 2022.
Jan Hetfleisch/Getty Images

Fueled by pandemic frustrations, populist parties are embracing anti-vaccine figures overseas, too

Public health officials worry as misinformation, pandemic-related grievances prove to be politically potent. "They identified this as a trigger topic."

By Andrew Joseph


HHS orders CDC to halt some vaccine ads, saying RFK Jr. wants message focused on ‘informed consent’

Kennedy, new head of HHS, halts paid promotion for "Wild to Mild" flu shot campaign to put more emphasis on potential vaccine risks, two sources tell STAT.

By Helen Branswell


Opinion: The ironic origin story behind Sloan Kettering

The men who built Sloan Kettering, one of the world’s leading cancer centers, also created and sold leaded gasoline — a destructive, carcinogenic poison.

By Daniel Stone


Adobe

STAT+ | Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders

FDA declares end to Novo Nordisk’s semaglutide shortage, a threat to online companies selling compounded versions of Ozempic, Wegovy.

By Elaine Chen


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.